We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
+10.57%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$148M
AUM Growth
+$20.9M
Cap. Flow
+$8.2M
Cap. Flow %
5.54%
Top 10 Hldgs %
22.4%
Holding
187
New
35
Increased
33
Reduced
72
Closed
23

Sector Composition

Rank Sector Weight
1 Healthcare 18.73%
2 Industrials 17.59%
3 Consumer Staples 14.02%
4 Technology 13.78%
5 Financials 12.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTLT
126
DELISTED
CATALENT, INC.
CTLT
$313K 0.21%
7,700
-450
-6% -$17.6K
BMRN icon
127
BioMarin Pharmaceuticals
BMRN
$12.5B
$311K 0.21%
+3,500
New +$324K
DXCM icon
128
DexCom
DXCM
$32.6B
$304K 0.21%
+10,200
New +$358K
CRM icon
129
Salesforce
CRM
$210B
$289K 0.2%
+1,825
New +$283K
DRI icon
130
Darden Restaurants
DRI
$23.7B
$288K 0.19%
2,373
CNBKA
131
DELISTED
Century Bancorp Inc/Mass
CNBKA
$287K 0.19%
3,926
ALK icon
132
Alaska Air
ALK
$4.45B
$285K 0.19%
5,075
+100
+2% +$6.11K
LNG icon
133
Cheniere Energy
LNG
$56B
$284K 0.19%
+4,150
New +$273K
IBP icon
134
Installed Building Products
IBP
$5.31B
$278K 0.19%
+5,725
New +$245K
NEE icon
135
NextEra Energy
NEE
$169B
$271K 0.18%
5,600
-2,400
-30% -$110K
WMT icon
136
Walmart Inc
WMT
$858B
$269K 0.18%
8,286
CMCSA icon
137
Comcast
CMCSA
$86.7B
$266K 0.18%
6,646
LOGI icon
138
Logitech
LOGI
$14.5B
$261K 0.18%
6,640
-2,650
-29% -$95.5K
SIVB
139
DELISTED
SVB Financial Group
SIVB
$261K 0.18%
+1,175
New +$274K
CF icon
140
CF Industries
CF
$20.5B
$258K 0.17%
6,300
+200
+3% +$8.48K
NVS icon
141
Novartis
NVS
$263B
$253K 0.17%
2,935
-112
-4% -$8.99K
AXTA icon
142
Axalta
AXTA
$7.12B
$252K 0.17%
10,000
-1,200
-11% -$30.9K
HSBC.PRA
143
DELISTED
HSBC Holdings PLC, Inc. ADS(1/40 shr. 6.2% Non-Cum. Dlr. Pref. Shrs., Ser.A)
HSBC.PRA
$250K 0.17%
9,700
CME icon
144
CME Group
CME
$98.9B
$248K 0.17%
+1,505
New +$266K
RMD icon
145
ResMed
RMD
$33.1B
$244K 0.16%
+2,350
New +$243K
AZN icon
146
AstraZeneca
AZN
$251B
$239K 0.16%
2,954
XPO icon
147
XPO
XPO
$20.9B
$239K 0.16%
+12,867
New +$247K
CTXS
148
DELISTED
Citrix Systems Inc
CTXS
$239K 0.16%
+2,400
New +$249K
ROK icon
149
Rockwell Automation
ROK
$46.3B
$237K 0.16%
1,350
-200
-13% -$34K
EYE icon
150
National Vision
EYE
$1.25B
$236K 0.16%
7,500
+200
+3% +$6.29K

Similar funds

New England Research & Management's Q1 2019 Portfolio in Review

As of Q1 2019, New England Research & Management held 187 positions worth $148M, up 16% from $127M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

New England Research & Management deployed $8.2M of net new capital in Q1 2019, opening 35 new positions and adding to 33 existing holdings. Its largest new stake was United Airlines: 20,648 shares worth $1.65M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Industrials and Consumer Staples.

On the sell side, the largest reduction was Union Pacific, an estimated $1.15M trimmed.

  • New England Research & Management's largest Q1 2019 buy was United Airlines: 20,648 shares worth $1.65M.
  • New England Research & Management added most to Coca-Cola in Q1 2019, an estimated $1.2M increase.
  • New England Research & Management's biggest Q1 2019 reduction was Union Pacific, cutting an estimated $1.15M.
  • New England Research & Management fully exited Baxter International in Q1 2019, selling an estimated $1.1M.
  • New England Research & Management's ten largest holdings make up 22% of its $148M portfolio in Q1 2019.
  • New England Research & Management opened 35 new positions and closed 23 in Q1 2019.
  • New England Research & Management's portfolio value rose 16% quarter-over-quarter to $148M.

Based on New England Research & Management's 13F filing for Q1 2019, filed 3 Apr 2019.